कंपनी का अवलोकन
P3 Health Partners Inc. operates as a patient-centered and physician-led population health management entity that delivers superior care services through the operation of various clinics and wellness centers across the United States. The company functions within the Healthcare sector, specifically the Medical Care Facilities industry, positioning it to capture value from the expanding demand for managed care and direct primary care models. Its current market capitalization stands at $597.32M, while its trailing twelve-month revenue reaches $1.46B, although the specific employee count is not disclosed in available data. These valuation and revenue metrics indicate a significant operational footprint within the domestic healthcare landscape, suggesting a substantial scale relative to peer entities in the medical care facilities space. The absence of employee data limits a precise assessment of labor density, but the revenue generation implies a robust network of service delivery points managed by the organization.
वित्तीय स्वास्थ्य
The company reported a revenue of $1.46B for the trailing twelve months, yet it posted a net income of $-147,948,000 and an EBITDA of $-186,138,000, revealing a substantial gap between top-line generation and profitability. This disparity highlights a cost structure where operating expenses and overheads significantly outpace gross margins, resulting in a net income figure that is roughly 81% of the total EBITDA loss. Despite these operational losses, the firm maintains a positive free cash flow of $16.28M, which provides a degree of financial flexibility to fund operations or strategic initiatives without immediate reliance on external equity financing. However, the liquidity position is constrained by a total cash balance of $25.01M against a total debt load of $287.28M, indicating a highly leveraged balance sheet where cash reserves cover less than 10% of obligations. The debt-to-equity ratio is listed as N/A, likely due to the negative equity position implied by the severe losses, further complicating leverage analysis. Furthermore, the current ratio stands at 0.24, signaling that the company's current assets are insufficient to cover its current liabilities, which points to potential short-term liquidity stress. Return on Equity is calculated at -6952.6% and Return on Assets at -23.5%, metrics that reflect the severe erosion of shareholder value and asset efficiency over the reporting period.
मूल्यांकन आकलन
Valuation multiples for P3 Health Partners Inc. present a challenging picture, with a P/E Ratio (TTM) listed as N/A and a Forward P/E of -14.00, implying that the market is pricing in a future turnaround to positive earnings rather than current profitability. The Price to Book ratio is -0.06, indicating that the stock trades at a significant discount to its book value, a scenario often associated with distressed assets or companies with substantial accumulated losses. Additionally, the Price to Sales ratio is 0.41 and the EV/EBITDA is -1.54, suggesting that alternative valuation metrics also reflect the company's current unprofitable status and negative earnings power. In terms of trading range, the stock has a 52-week high of $11.30 and a 52-week low of $1.52, meaning the current price sits within this volatile band but specifically trades significantly below the recent high of $11.30. The stock exhibits a Beta of 0.85, which indicates that its price volatility is slightly lower than the broader market, suggesting it may be less sensitive to general market fluctuations compared to the S&P 500.
Growth & Income
P3 Health Partners Inc. demonstrated a revenue growth rate of 3.8% year-over-year, whereas earnings growth is listed as N/A due to the persistent losses, indicating that top-line expansion is occurring without a corresponding improvement in bottom-line profitability. As a non-dividend payer, the company has a Dividend Yield of N/A and a Payout Ratio of 0.0%, meaning it does not distribute cash to shareholders and instead retains all earnings to address operational deficits or fund growth initiatives. The absence of a dividend payout is consistent with the negative Net Income and negative EBITDA, as the company lacks the distributable earnings required to sustain a dividend policy. Overall, the growth and income profile is characterized by modest revenue expansion coupled with significant earnings contraction and zero income distribution to investors.